GYEMSZI - MOB

Heimesaat, Markus M. - Kapcsolódó tételek

1.			Absinthe against multi-drug resistant bacterial pathogens? : a recent update on the antibacterial effects of Artemisia compounds
2.			Antibacterial effects of biologically active ingredients in hop provide promising options to fight infections by pathogens including multi-drug resistant bacteria
3.			Antibacterial effects of vanilla ingredients provide novel treatment options for infections with multidrug-resistant bacteria - A recent literature review
4.			Antibacterial properties of capsaicin and its derivatives and their potential to fight antibiotic resistance - A literature survey
5.			Anti-inflammatory effects of the octapeptide NAP in human microbiota-associated mice suffering from subacute ileitis
6.			Anti-Inflammatory Properties of NAP in Acute Toxoplasma gondii-Induced Ileitis in Mice
7.			Antimicrobial and Immune-Modulatory Effects of Vitamin D Provide Promising Antibiotics-Independent Approaches to Tackle Bacterial Infections - Lessons Learnt from a Literature Survey
8.			Binary surrogate endpoints in clinical trials from the perspective of case definitions
9.			Campylobacter jejuni infection induces acute enterocolitis in IL-10-/- mice pretreated with ampicillin plus sulbactam
10.			Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni?
11.			Changes of the intestinal microbiome-host homeostasis in HIV-infected individuals - a focus on the bacterial gut microbiome
12.			Chronic otitis media following infection by non-O1/non-O139 Vibrio cholerae: A case report and review of the literature
13.			Colonic Expression of Genes Encoding Inflammatory Mediators and Gelatinases During Campylobacter Jejuni Infection of Conventional Infant Mice
14.			Colonization resistance against genetically modified Escherichia coli K12 (W3110) strains is abrogated following broad-spectrum antibiotic treatment and acute ileitis
15.			Commensal microbiota drive proliferation of conventional and Foxp3+ Regulatory CD4+ T cells in mesenteric lymph nodes and Peyer's patches
16.			Comprehensive survey of intestinal microbiota changes in offspring of human microbiota associated mice
17.			The conundrum of colonization resistance against Campylobacter reloaded: The gut microbota composition in conventional mice does not prevent from Campylobacter coli infection
18.			Dissecting the interplay between intestinal microbiota and host immunity in health and disease: Lessons learned from germfree and gnotobiotic animal models
19.			Evaluation of the Xiamen AmonMed Biotechnology rapid diagnostic test COVID-19 IgM/IgG test kit (Colloidal gold)
20.			Fecal Microbiota Transplantation Decreases Intestinal Loads of Multi-Drug Resistant Pseudomonas aeruginosa in Murine Carriers
21.			Finding novel antibiotic substances from medicinal plants - Antimicrobial properties of Nigella sativa directed against multidrug resistant bacteria
22.			Function of serine protease HtrA in the lifecycle of the foodborne pathogen Campylobacter jejuni
23.			Human microbiota associated IL-10-/- mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota
24.			Immunomodulatory and Antimicrobial Effects of Vitamin C
25.			Impact of metal ion homeostasis of genetically modified Escherichia coli Nissle 1917 and K12 (W3110) strains on colonization properties in the murine intestinal tract
26.			Intestinal expression of genes encoding inflammatory mediators and gelatinases during Arcobacter butzleri infection of gnotobiotic IL-10 deficient mice
27.			Intestinal microbiota changes in mice lacking pituitary adenylate cyclase activating polypeptide (PACAP) - bifidobacteria make the difference
28.			A literature survey on antimicrobial and immune-modulatory effects of butyrate revealing non-antibiotic approaches to tackle bacterial infections
29.			Matrix Metalloproteinase-2 Mediates Intestinal Immunopathogenesis in Campylobacter jejuni-infected infant mice
30.			Microbiota composition and immune responses during Campylobacter jejuni infection in conventionally colonized IL-10-/- mice lacking nucleotide oligomerization domain 2
31.			Microbiota composition and inflammatory immune responses upon peroral application of the commercial competitive exclusion product Aviguard(R) to microbiota-depleted wildtype mice
32.			Modulation of the intestinal microbiota impacts the efficacy of immunotherapy in cancer patients - A recent literature survey
33.			Multidrug-resistant Pseudomonas aeruginosa induce systemic pro-inflammatory immune responses in colonized mice
34.			Peroral low-dose Toxoplasma gondii infection of human microbiota-associated mice - a subacute ileitis model to unravel pathogen-host interactions
35.			A review of the antimicrobial and immune-modulatory properties of the gut microbiota-derived short chain fatty acid propionate - What is new?
36.			Review of therapeutic options for infections with carbapenem-resistant Klebsiella pneumoniae
37.			The role of gelatinases in Campylobacter jejuni infection of gnotobiotic mice
38.			The Role of IL-23, IL-22, and IL-18 in Campylobacter Jejuni Infection of Conventional Infant Mice
39.			Saponins increase susceptibility of vancomycin-resistant enterococci to antibiotic compounds
40.			Small intestinal pro-inflammatory immune responses following Campylobacter jejuni infection of secondary abiotic IL-10-/- mice lacking nucleotide-oligomerization-domain-2
41.			Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice
42.			Synergistic Antimicrobial Effects of Cefabronchin
43.			Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondii
44.			Toll-like receptor-4 dependent inflammatory responses following intestinal colonization of secondary abiotic IL10-deficient mice with multidrug-resistant Pseudomonas aeruginosa
45.			Toll-like receptor-4 dependent intestinal gene expression during Arcobacter butzleri infection of gnotobiotic IL-10 deficient mice
46.			Toll-like receptor-4 dependent small intestinal immune responses following murine Arcobacter butzleri infection
47.			Toll-like receptor-4 is essential for Arcobacter butzleri-induced colonic and systemic immune responses in gnotobiotic IL-10-/- mice
48.			Vitamin E as promising adjunct treatment option in the combat of infectious diseases caused by bacterial including multi-drug resistant pathogens - Results from a comprehensive literature survey

Mind kijelölve: